your badges 52W Range $1–$3 43% of range Analyst Rating BUY 16 analysts Price Target $9 +390% upside P/E -1.7 ROE -133.0% Net Profit Margin -238.7%

AUTL Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range

03
Price $1.78
P/E (TTM) -1.7
EPS (TTM) $-1.06
Revenue (TTM) $117M
ROE (TTM) -133.0%
52W Range $1–$3

AUTL Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view

04
range
bars

Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.

10-Year Performance Revenue, net income, margins and EPS trends

06
Revenue$75M
2023-12-31 → 2025-12-31
EPS$-1.08
2022-12-31 → 2025-12-31
Free Cash Flow$-303M
2023-12-31 → 2025-12-31
Net margin-238.7%
2024-12-31 → 2025-12-31
Valuation & Ratios 07–12

Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?

Metric 5Y trend AUTL 5Y avg Peer Median Verdict
P/E (TTM) -1.75Y avg ≈-3.3 ≈-3.3 · ·

Peer median is calculated on a standardized basis per metric and may not always match the TTM/MRQ basis shown for this stock.

value · ≈ 5Y avg · industry median · verdict relative to median

Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date

14
Avg Surprise 7.0%
Next Report Nov 10, 2026
PeriodReportEPS ActualEPS EstSurprise
June 30, 2026 Aug 11, 2026 $-0.15 $-0.22 31.8%
March 31, 2026 May 14, 2026 $-0.27 $-0.26 -2.9%
Dec. 31, 2025 $-0.34 $-0.27 -25.2%
Sept. 30, 2025 $-0.30 $-0.23 -30.3%
June 30, 2025 $-0.18 $-0.24 25.1%
March 31, 2025 $-0.26 $-0.26 -2.0%
Dec. 31, 2024 $-0.10 $-0.21 52.3%

Full Fundamentals All metrics by year — income statement, balance sheet, cash flow

15
Income Statement 16
Metric Trend 202520242023
Revenue $75M$10M$2M
Cost of Revenue $96M$11M$0
R&D Expense $118M$138M$130M
SG&A Expense $132M$102M$47M
Operating Income $-271M$-241M$-180M
Interest Expense $37M$9M$45M
Interest Income $19M$32M$14M
Other Non-op $515.0K$220.0K$222.0K
Pretax Income $-286M$-219M$-208M
Income Tax $2M$2M$-19.0K
Net Income $-288M$-221M$-208M
EPS (Basic) $-1.08$-0.86$-1.20
EPS (Diluted) $-1.08$-0.86$-1.20
Shares (Basic) 266,138,224255,161,038173,941,926
Shares (Diluted) 266,138,224255,161,038173,941,926
EBITDA $-262M$-234M$-173M
Balance Sheet 21
Metric Trend 202520242023
Cash & Equivalents $104M$227M$240M
Receivables $24M$15.0K$109.0K
Inventory $33M$4M$0
Prepaid Expense $76M$67M$35M
Other Current Assets $0$2M$0
Current Assets $436M$661M$275M
PP&E (Net) $64M$50M$35M
Accum. Depreciation $44M$35M$29M
Intangibles $20M$12M$0
Total Assets $589M$783M$375M
Accounts Payable $3M$2M$103.0K
Accrued Liabilities $56M$52M$40M
Current Liabilities $73M$61M$45M
Capital Leases $67M$50M$48M
Other Non-current Liabilities $477.0K$426.0K$357.0K
Total Liabilities $411M$355M$264M
Paid-in Capital $1.57B$1.56B$1.02B
Retained Earnings $-1.39B$-1.10B$-879M
AOCI $-5M$-29M$-29M
Stockholders' Equity $178M$427M$111M
Liabilities + Equity $589M$783M$375M
Cash Flow 15
Metric Trend 202520242023
D&A $8M$8M$7M
Deferred Tax $-631.0K$-175.0K$-987.0K
Amort. of Intangibles $2M$162.0K$0
Restructuring $2M··
Other Non-cash $-4M$7M$57M
Operating Cash Flow $-284M$-206M$-146M
CapEx $19M$22M$11M
Investing Cash Flow $158M$-395M$-11M
Stock Issued $0$550M$0
Net Stock Activity $0$550M$0
Financing Cash Flow $-4M$590M$-883.0K
Net Change in Cash $-123M$-12M$-142M
Taxes Paid $2M$2M$551.0K
Free Cash Flow $-303M$-228M$-157M
Levered FCF $-340M$-238M$-202M
Profitability 7
Metric Trend 202520242023
Operating Margin -358.9%-2385.6%·
Net Margin -381.4%-2180.5%·
Pretax Margin -378.8%-2165.4%·
EBITDA Margin -347.9%-2311.0%·
ROA -41.9%-38.1%-53.3%
ROE -109.6%-48.8%-142.7%
ROIC -152.9%-56.9%-161.2%
Liquidity & Solvency 3
Metric Trend 202520242023
Current Ratio 5.910.96.2
Quick Ratio 1.73.75.4
Interest Coverage -7.4-26.0-4.0
Efficiency 3
Metric Trend 202520242023
Asset Turnover 0.10.0·
Inventory Turnover 5.25.5·
Receivables Turnover 6.3163.2·
Per Share 3
Metric Trend 202520242023
Revenue / Share $0.28$0.04·
Cash Flow / Share $-1.07$-0.81$-0.84
EPS (TTM) $-1.08$-0.86$-1.20
Growth Rates 1
Metric Trend 202520242023
Revenue YoY 644.9%496.0%·
Valuation (TTM) 4
Metric Trend 202520242023
Revenue TTM $75M$10M$2M
Net Income TTM $-288M$-221M$-208M
P/E -1.8-2.7-5.4
Earnings Yield -54.3%-36.6%-18.6%

Most recent period on the left · null values shown as ·

Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years

16
Metric 2025-12-312024-12-312023-12-312023-09-302023-06-30
Revenue $75M $10M $2M · ·
Operating Margin % -358.9% -2385.6% · · ·
Net Income $-288M $-221M $-208M · ·
Diluted EPS $-1.08 $-0.86 $-1.20 · ·

Institutional owners (13F) 86 filers · $217.3M total · As of June 30, 2026

17

Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.

Holders 86
Value held $217.3M
New positions 10
Exited positions 10
Institutional activity — Q2 2026 vs prior quarter
New positions Exited positions Increased Decreased Net shares change
10 (-1 vs prior Q) 10 (-3 vs prior Q) 27 (+3 vs prior Q) 21 (-7 vs prior Q) +18.3M

Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.

Institution Value Shares % of tracked 13F Type
MAK CAPITAL ONE LLC $53,794,379 33,621,487 24.76% Shares
Blackstone Inc. $32,776,978 20,485,611 15.08% Shares
Syncona Portfolio Ltd $26,625,152 16,640,720 12.25% Shares
ARMISTICE CAPITAL, LLC $24,000,000 15,000,000 11.05% Shares
Tetragon Partners GP Ltd $15,200,000 9,500,000 7.00% Shares
SCHRODER INVESTMENT MANAGEMENT GROUP $12,924,915 7,833,282 5.95% Shares
Frazier Life Sciences Management, L.P. $7,116,656 4,447,910 3.28% Shares
AXA Investment Managers S.A. $5,478,684 3,361,156 2.52% Shares
BNP PARIBAS ASSET MANAGEMENT Holding S.A. $5,377,850 3,361,156 2.47% Shares
Laurion Capital Management LP $5,306,602 3,316,626 2.44% Shares
RENAISSANCE TECHNOLOGIES LLC $3,175,520 1,984,700 1.46% Shares
BANK OF AMERICA CORP /DE/ $2,568,147 1,605,092 1.18% Shares
BlackRock, Inc. $2,565,532 1,603,458 1.18% Shares
UBS Group AG $2,427,186 1,516,991 1.12% Shares
MORGAN STANLEY $2,017,331 1,260,832 0.93% Shares
MILLENNIUM MANAGEMENT LLC $1,959,709 1,224,818 0.90% Shares
Cetera Investment Advisers $1,851,718 1,157,324 0.85% Shares
Balyasny Asset Management L.P. $1,556,397 972,748 0.72% Shares
JPMORGAN CHASE & CO $1,506,844 913,239 0.69% Shares
Alphabet Inc. $1,117,219 698,262 0.51% Shares
CITADEL ADVISORS LLC $1,113,424 695,890 0.51% Shares
Privium Fund Management B.V. $581,488 363,430 0.27% Shares
JANE STREET GROUP, LLC $479,779 299,862 0.22% Shares
EDENTREE ASSET MANAGEMENT Ltd $477,000 300,000 0.22% Shares
XTX Topco Ltd $459,930 287,456 0.21% Shares
WELLS FARGO & COMPANY/MN $340,147 212,592 0.16% Shares
JANE STREET GROUP, LLC $337,920 211,200 0.16% Call option
Erste Asset Management GmbH $321,750 195,000 0.15% Shares
DAFNA Capital Management LLC $286,906 179,316 0.13% Shares
SUSQUEHANNA INTERNATIONAL GROUP, LLP $283,572 177,232 0.13% Shares
Cubist Systematic Strategies, LLC $259,835 159,408 0.12% Shares
NANO CAP NEW MILLENNIUM GROWTH FUND L P $240,000 150,000 0.11% Shares
GEODE CAPITAL MANAGEMENT, LLC $198,294 123,934 0.09% Shares
Clearstead Advisors, LLC $193,772 121,107 0.09% Shares
Quadrature Capital Ltd $183,813 114,883 0.08% Shares
GOLDMAN SACHS GROUP INC $181,690 113,556 0.08% Shares
CITADEL ADVISORS LLC $175,840 109,900 0.08% Call option
Leonteq Securities AG $160,000 100,000 0.07% Shares
MARSHALL WACE, LLP $151,445 94,654 0.07% Shares
STATE STREET CORP $135,054 84,409 0.06% Shares
Point72 Asset Management, L.P. $113,963 71,227 0.05% Shares
Invesco Ltd. $106,315 66,447 0.05% Shares
SmartHarvest Portfolios, LLC $101,763 63,602 0.05% Shares
HighPoint Advisor Group LLC $91,200 57,000 0.04% Shares
LPL Financial LLC $68,200 42,625 0.03% Shares
RHUMBLINE ADVISERS $62,017 38,764 0.03% Shares
R Squared Ltd $58,282 36,426 0.03% Shares
FOREFRONT WEALTH MANAGEMENT INC. $53,471 26,870 0.02% Shares
China Universal Asset Management Co., Ltd. $51,080 31,925 0.02% Shares
Rathbones Group PLC $44,880 28,050 0.02% Shares

Show all 86 institutional owners →

Activists & 5%+ owners 6 positions

18

Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.

Filer Filed Stake Status Purpose Filing
AMALAR HOLDING s.r.o., PPF Group a.s., PPF IM Ltd., Renata Kellnerova Aug. 28, 2026 5.60% Amendment · SEC
Renata Kellnerova, AMALAR HOLDING s.r.o., PPF GROUP N.V., PPF BIOTECH B.V. ×4 filings Oct. 25, 2024 · Initial filing · SEC
BXLS V – Autobahn L.P., Blackstone Life Sciences Associates V (CYM) L.L.C., Blackstone Clarus GP L.L.C., Blackstone Holdings I L.P., Blackstone Holdings I/II GP L.L.C., Blackstone Inc., Blackstone Group Management L.L.C., Stephen A. Schwarzman ×3 filings May 21, 2024 · Initial filing · SEC
BioNTech SE Feb. 21, 2024 · Initial filing Board campaign SEC
Arix Bioscience Plc, Arix Bioscience Holdings Limited ×3 filings Feb. 17, 2021 · Initial filing · SEC
PETR KELLNER, PPF GROUP N.V., PPF CAPITAL PARTNERS FUND B.V. ×7 filings Aug. 13, 2020 · Initial filing · SEC

Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.

Company insiders 10 insiders · 1 officers · 9 directors

19
Insider Role Last activity Shares owned Buys 12m Sells 12m Net 12m
Cintia Piccina U.S. CCO & Country Gen Manager Sept. 1, 2026 M 13,287 0 1 $-15,708
Ryan Richardson Director June 29, 2026 A · 0 0 $0
Elisabeth Leiderman Director June 29, 2026 A · 0 0 $0
Madduri Ravin Rao Director June 29, 2026 A · 0 0 $0
Robert Iannone Director June 29, 2026 A · 0 0 $0
Robert Azelby Director June 29, 2026 A · 0 0 $0
Linda Bain Director June 29, 2026 A · 0 0 $0
Cynthia M Butitta Director June 29, 2026 A · 0 0 $0
Michael W Bonney Director June 29, 2026 A · 0 0 $0
William D Young Director June 29, 2026 A · 0 0 $0

Insiders from SEC Form 3/4/5 filings; net = open-market P/S only

ETF ownership Held by 3 ETFs

20

Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.

Fund Weight Units As of Source
QQQS · Invesco Exchange-Traded Fund Trust … 0.41% 50,741 SH Oct. 2, 2026 Daily
IBB · iShares Trust 0.03% 1,523,114 SH Sept. 11, 2026 Daily
IBBQ · Invesco Exchange-Traded Fund Trust … 0.02% 14,180 SH Oct. 2, 2026 Daily

AUTL Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside

21
rating · 16 analysts BUY
Median target $9.50 +433.7%
6 37.5% Strong Buy
9 56.2% Buy
1 6.2% Hold
0 0.0% Sell
0 0.0% Strong Sell

12-Month Price Target

8 analysts · 2026-09-27

Mean target $8.72 +390.2%

← Below all targets Current price $1.78
Low$5.00 Mean$8.72 High$11.00

Peer comparison (GICS sub-industry) Key metrics vs sector peers

22

FY basis, prices as of each company's last fiscal year-end close.

Ticker Market Cap P/E Rev YoY Net Margin ROE Gross Margin
AUTL · -1.8 644.9% -381.4% -109.6% ·
IMCR $1.76B -48.9 28.9% -8.9% -9.2% ·
BCYC $491M -2.2 105.8% -301.7% -34.2% ·
TLSA · -9.3 · · -924.3% ·

Latest News Recent headlines mentioning this company

23
Mizuho Lowers its Price Target on Autolus Therapeutics plc (AUTL) to $10 from $12 Yahoo Finance · 5 months, 4 weeks ago

My Metrics Your personal watchlist — selected rows from Full Fundamentals

26

Pick the metrics that matter to you — click the + next to any row in Full Fundamentals above.

Your selection is saved and follows you across all tickers.

Source: SEC 10-Q filed Aug 11, 2026